English

Zhong Yuan Bio-Technology Holdings Ltd

EDGAR

Annual report for a foreign issuer (20-F) · filed 2024-11-07

36 filing records in this dataset, filed from 2016-08-15 to 2024-11-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2018 Q2 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Cash and cash equivalents: Not available
Long-term debt including current maturities: 1.89 million USD 2024-03-31 Source
Exact value

1887458 USD
Shares outstanding: 17.7 million shares 2024-03-31 Source
Exact value

17709718 shares

Reported share-count change

0.17% · 30.1 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

17679618 shares · 2023-03-31· Source
17709718 shares · 2024-03-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-11-07.

Financial data available through: 2024-03-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2024-03-31
Operating income: 6 of 11 periods available· newest 2024-03-31
Net income: 6 of 11 periods available· newest 2024-03-31
Operating cash flow: 6 of 11 periods available· newest 2024-03-31
Capital expenditure: 5 of 11 periods available· newest 2023-03-31
Total assets: 6 of 11 periods available· newest 2024-03-31
Total liabilities: 6 of 11 periods available· newest 2024-03-31
Current assets: 6 of 11 periods available· newest 2024-03-31
Current liabilities: 6 of 11 periods available· newest 2024-03-31
cash and cash equivalents: No compatible figures in this window
Long-term debt including current maturities: 1 of 11 periods available· newest 2024-03-31
Shares outstanding: 6 of 11 periods available· newest 2024-03-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+37%

Prior period

USD 1.66 million

2022-04-01 – 2023-03-31
Current period

USD 2.28 million

2023-04-01 – 2024-03-31

Exact inputs and evidence

2278246 − 1662600 = 615646 USD

1662600 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source
2278246 USD · 2023-04-01 – 2024-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Zhong Yuan Bio-Technology Holdings Ltd · 2024-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Year-over-year change in Revenue: 615646 USD Concept: fundies:Revenue Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2278246 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1420314 Filing: 000107997324001482 Input fundies:Revenue: 1662600 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2271394 Filing: 000107997324001482
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.48 million

Prior period

−USD 2.2 million

2022-04-01 – 2023-03-31
Current period

USD 271,869

2023-04-01 – 2024-03-31

Exact inputs and evidence

271869 − -2204126 = 2475995 USD

-2204126 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source
271869 USD · 2023-04-01 – 2024-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Zhong Yuan Bio-Technology Holdings Ltd · 2024-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Year-over-year change in Net income: 2475995 USD Concept: fundies:NetIncome Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 271869 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1767439 Filing: 000107997324001482 Input fundies:NetIncome: -2204126 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2323287 Filing: 000107997324001482
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 279,543

Prior period

−USD 1.03 million

2022-04-01 – 2023-03-31
Current period

−USD 745,816

2023-04-01 – 2024-03-31

Exact inputs and evidence

-745816 − -1025359 = 279543 USD

-1025359 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source
-745816 USD · 2023-04-01 – 2024-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Zhong Yuan Bio-Technology Holdings Ltd · 2024-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Year-over-year change in Operating cash flow: 279543 USD Concept: fundies:OperatingCashFlow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -745816 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1604238 Filing: 000107997324001482 Input fundies:OperatingCashFlow: -1025359 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1604699 Filing: 000107997324001482
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2023-04-01 – 2024-03-31

Revenue USD 2.28 million 100% of revenue
Operating costs Derived USD 2.01 million 88% of revenue
Operating income USD 266,557 12% of revenue
Tax, interest and other Derived −USD 5,312 −0.2% of revenue
Net income USD 271,869 12% of revenue

Cash

Operating cash flow −USD 745,816 −33% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 23%74%
2020 Operating loss: operating costs were 107% of revenue.
2021 Operating loss: operating costs were 101% of revenue.
2022 Operating loss: operating costs were 148% of revenue.
2023 Operating loss: operating costs were 197% of revenue.
2024 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2018-04-01 – 2019-03-31	1217588	905452 Derived	312136	31953 Derived	280183	757527 Derived	Source 2018-04-01 – 2019-03-31: 1217588 USD Inspect Revenue Open source 2018-04-01 – 2019-03-31: 312136 USD Inspect Operating Income Open source 2018-04-01 – 2019-03-31: 280183 USD Inspect Net Income Open source 2018-04-01 – 2019-03-31: 757527 USD Inspect Operating Cash Flow Open source 2018-04-01 – 2019-03-31: 0 USD Inspect Capital Expenditure Open source
2020 2019-04-01 – 2020-03-31	1219650	1305159 Derived	-85509	1790 Derived	-87299	-154144 Derived	Source 2019-04-01 – 2020-03-31: 1219650 USD Inspect Revenue Open source 2019-04-01 – 2020-03-31: -85509 USD Inspect Operating Income Open source 2019-04-01 – 2020-03-31: -87299 USD Inspect Net Income Open source 2019-04-01 – 2020-03-31: -146573 USD Inspect Operating Cash Flow Open source 2019-04-01 – 2020-03-31: 7571 USD Inspect Capital Expenditure Open source
2021 2020-04-01 – 2021-03-31	1635420	1650015 Derived	-14595	13427 Derived	-28022	303563 Derived	Source 2020-04-01 – 2021-03-31: 1635420 USD Inspect Revenue Open source 2020-04-01 – 2021-03-31: -14595 USD Inspect Operating Income Open source 2020-04-01 – 2021-03-31: -28022 USD Inspect Net Income Open source 2020-04-01 – 2021-03-31: 309195 USD Inspect Operating Cash Flow Open source 2020-04-01 – 2021-03-31: 5632 USD Inspect Capital Expenditure Open source
2022 2021-04-01 – 2022-03-31	2328526	3457712 Derived	-1129186	-3621 Derived	-1125565	-255747 Derived	Source 2021-04-01 – 2022-03-31: 2328526 USD Inspect Revenue Open source 2021-04-01 – 2022-03-31: -1129186 USD Inspect Operating Income Open source 2021-04-01 – 2022-03-31: -1125565 USD Inspect Net Income Open source 2021-04-01 – 2022-03-31: -255747 USD Inspect Operating Cash Flow Open source 2021-04-01 – 2022-03-31: -0 USD Inspect Capital Expenditure Open source
2023 2022-04-01 – 2023-03-31	1662600	3268936 Derived	-1606336	597790 Derived	-2204126	-1047728 Derived	Source 2022-04-01 – 2023-03-31: 1662600 USD Inspect Revenue Open source 2022-04-01 – 2023-03-31: -1606336 USD Inspect Operating Income Open source 2022-04-01 – 2023-03-31: -2204126 USD Inspect Net Income Open source 2022-04-01 – 2023-03-31: -1025359 USD Inspect Operating Cash Flow Open source 2022-04-01 – 2023-03-31: 22369 USD Inspect Capital Expenditure Open source
2024 2023-04-01 – 2024-03-31	2278246	2011689 Derived	266557	-5312 Derived	271869	Unavailable	Source 2023-04-01 – 2024-03-31: 2278246 USD Inspect Revenue Open source 2023-04-01 – 2024-03-31: 266557 USD Inspect Operating Income Open source 2023-04-01 – 2024-03-31: 271869 USD Inspect Net Income Open source 2023-04-01 – 2024-03-31: -745816 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.3M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-03-31	Revenue	1217588	Revenue: 1217588 Open source
20202020-03-31	Revenue	1219650	Revenue: 1219650 Open source
20212021-03-31	Revenue	1635420	Revenue: 1635420 Open source
20222022-03-31	Revenue	2328526	Revenue: 2328526 Open source
20232023-03-31	Revenue	1662600	Revenue: 1662600 Open source
20242024-03-31	Revenue	2278246	Revenue: 2278246 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

37% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-03-31	Year over year	No prior comparable period	Revenue: 1217588 Open source
20202020-03-31	Year over year	0.2%	Revenue: 1219650 Open source Revenue: 1217588 Open source
20212021-03-31	Year over year	34.1%	Revenue: 1635420 Open source Revenue: 1219650 Open source
20222022-03-31	Year over year	42.4%	Revenue: 2328526 Open source Revenue: 1635420 Open source
20232023-03-31	Year over year	-28.6%	Revenue: 1662600 Open source Revenue: 2328526 Open source
20242024-03-31	Year over year	37%	Revenue: 2278246 Open source Revenue: 1662600 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 11.7% 2024

Net margin 11.9% 2024

Free cash flow margin -63% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-03-31	Operating margin	25.6%	Operating Income: 312136 Open source Revenue: 1217588 Open source
20202020-03-31	Operating margin	-7%	Operating Income: -85509 Open source Revenue: 1219650 Open source
20212021-03-31	Operating margin	-0.9%	Operating Income: -14595 Open source Revenue: 1635420 Open source
20222022-03-31	Operating margin	-48.5%	Operating Income: -1129186 Open source Revenue: 2328526 Open source
20232023-03-31	Operating margin	-96.6%	Operating Income: -1606336 Open source Revenue: 1662600 Open source
20242024-03-31	Operating margin	11.7%	Operating Income: 266557 Open source Revenue: 2278246 Open source
20192019-03-31	Net margin	23%	Net Income: 280183 Open source Revenue: 1217588 Open source
20202020-03-31	Net margin	-7.2%	Net Income: -87299 Open source Revenue: 1219650 Open source
20212021-03-31	Net margin	-1.7%	Net Income: -28022 Open source Revenue: 1635420 Open source
20222022-03-31	Net margin	-48.3%	Net Income: -1125565 Open source Revenue: 2328526 Open source
20232023-03-31	Net margin	-132.6%	Net Income: -2204126 Open source Revenue: 1662600 Open source
20242024-03-31	Net margin	11.9%	Net Income: 271869 Open source Revenue: 2278246 Open source
20192019-03-31	Free cash flow margin	62.2%	Revenue: 1217588 Open source Operating Cash Flow: 757527 Open source Capital Expenditure: 0 Open source
20202020-03-31	Free cash flow margin	-12.6%	Revenue: 1219650 Open source Operating Cash Flow: -146573 Open source Capital Expenditure: 7571 Open source
20212021-03-31	Free cash flow margin	18.6%	Revenue: 1635420 Open source Operating Cash Flow: 309195 Open source Capital Expenditure: 5632 Open source
20222022-03-31	Free cash flow margin	-11%	Revenue: 2328526 Open source Operating Cash Flow: -255747 Open source Capital Expenditure: -0 Open source
20232023-03-31	Free cash flow margin	-63%	Revenue: 1662600 Open source Operating Cash Flow: -1025359 Open source Capital Expenditure: 22369 Open source
20242024-03-31	Free cash flow margin	Not reported	Revenue: 2278246 Open source Operating Cash Flow: -745816 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -745.8K 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-03-31	Operating cash flow	757527	Operating Cash Flow: 757527 Open source
20202020-03-31	Operating cash flow	-146573	Operating Cash Flow: -146573 Open source
20212021-03-31	Operating cash flow	309195	Operating Cash Flow: 309195 Open source
20222022-03-31	Operating cash flow	-255747	Operating Cash Flow: -255747 Open source
20232023-03-31	Operating cash flow	-1025359	Operating Cash Flow: -1025359 Open source
20242024-03-31	Operating cash flow	-745816	Operating Cash Flow: -745816 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-03-31	Free cash flow	757527	Operating Cash Flow: 757527 Open source Capital Expenditure: 0 Open source
20202020-03-31	Free cash flow	-154144	Operating Cash Flow: -146573 Open source Capital Expenditure: 7571 Open source
20212021-03-31	Free cash flow	303563	Operating Cash Flow: 309195 Open source Capital Expenditure: 5632 Open source
20222022-03-31	Free cash flow	-255747	Operating Cash Flow: -255747 Open source Capital Expenditure: -0 Open source
20232023-03-31	Free cash flow	-1047728	Operating Cash Flow: -1025359 Open source Capital Expenditure: 22369 Open source
20242024-03-31	Free cash flow	Unavailable	Operating Cash Flow: -745816 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

106.9% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-03-31	Liabilities / assets	22.6%	Total Liabilities: 423647 Open source Total Assets: 1875718 Open source
20202020-03-31	Liabilities / assets	35.1%	Total Liabilities: 799647 Open source Total Assets: 2279457 Open source
20212021-03-31	Liabilities / assets	56.6%	Total Liabilities: 1957103 Open source Total Assets: 3457596 Open source
20222022-03-31	Liabilities / assets	67%	Total Liabilities: 1911475 Open source Total Assets: 2852875 Open source
20232023-03-31	Liabilities / assets	132%	Total Liabilities: 2815982 Open source Total Assets: 2133728 Open source
20242024-03-31	Liabilities / assets	106.9%	Total Liabilities: 3387027 Open source Total Assets: 3168233 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.82× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-03-31	Current assets / current liabilities	4.41×	Current Assets: 1866375 Open source Current Liabilities: 423647 Open source
20202020-03-31	Current assets / current liabilities	2.43×	Current Assets: 1529238 Open source Current Liabilities: 628681 Open source
20212021-03-31	Current assets / current liabilities	3.2×	Current Assets: 2436594 Open source Current Liabilities: 761242 Open source
20222022-03-31	Current assets / current liabilities	2.49×	Current Assets: 2082902 Open source Current Liabilities: 835574 Open source
20232023-03-31	Current assets / current liabilities	0.47×	Current Assets: 1043437 Open source Current Liabilities: 2207914 Open source
20242024-03-31	Current assets / current liabilities	0.82×	Current Assets: 2026173 Open source Current Liabilities: 2482686 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2018-04-01 – 2019-03-31	USD 280,183 Exact value Exact value: 280183 USD 2018-04-01 – 2019-03-31: 280183 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zhong Yuan Bio-Technology Holdings Ltd · 2019-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Net Income: 280183 USD Concept: fundies:NetIncome Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ANetIncome&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:NetIncome: 280183 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997320000706/cbio-20200331.xml#44169 Filing: 000107997320000706 The citation records this snapshot. The page link may show a newer release later.	USD 757,527 Exact value Exact value: 757527 USD 2018-04-01 – 2019-03-31: 757527 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zhong Yuan Bio-Technology Holdings Ltd · 2019-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Operating Cash Flow: 757527 USD Concept: fundies:OperatingCashFlow Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3AOperatingCashFlow&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 757527 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997320000706/cbio-20200331.xml#42817 Filing: 000107997320000706 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2018-04-01 – 2019-03-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zhong Yuan Bio-Technology Holdings Ltd · 2019-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ACapitalExpenditure&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997320000706/cbio-20200331.xml#63946 Filing: 000107997320000706 The citation records this snapshot. The page link may show a newer release later.	USD 757,527 Calculation and evidence 757527 − 0 USD Exact free cash flow: 757527 USD 2018-04-01 – 2019-03-31: 757527 USD · Inspect Operating Cash Flow · Source 2018-04-01 – 2019-03-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zhong Yuan Bio-Technology Holdings Ltd · 2019-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Free cash flow: 757527 USD Concept: free-cash-flow Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 757527 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997320000706/cbio-20200331.xml#42817 Filing: 000107997320000706 Input fundies:CapitalExpenditure: 0 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997320000706/cbio-20200331.xml#63946 Filing: 000107997320000706 The citation records this snapshot. The page link may show a newer release later.
2020 2019-04-01 – 2020-03-31	−USD 87,299 Exact value Exact value: -87299 USD 2019-04-01 – 2020-03-31: -87299 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zhong Yuan Bio-Technology Holdings Ltd · 2020-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Net Income: -87299 USD Concept: fundies:NetIncome Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ANetIncome&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:NetIncome: -87299 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997322001360/zhongyuan_f1.htm#2019110 Filing: 000107997322001360 The citation records this snapshot. The page link may show a newer release later.	−USD 146,573 Exact value Exact value: -146573 USD 2019-04-01 – 2020-03-31: -146573 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zhong Yuan Bio-Technology Holdings Ltd · 2020-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Operating Cash Flow: -146573 USD Concept: fundies:OperatingCashFlow Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3AOperatingCashFlow&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -146573 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997322001360/zhongyuan_f1.htm#2031728 Filing: 000107997322001360 The citation records this snapshot. The page link may show a newer release later.	USD 7,571 Exact value Exact value: 7571 USD 2019-04-01 – 2020-03-31: 7571 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zhong Yuan Bio-Technology Holdings Ltd · 2020-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Capital Expenditure: 7571 USD Concept: fundies:CapitalExpenditure Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ACapitalExpenditure&period=2020-03-31&surface=latest&period_type=duration&start=2019-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7571 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997322001360/zhongyuan_f1.htm#2036361 Filing: 000107997322001360 The citation records this snapshot. The page link may show a newer release later.	−USD 154,144 Calculation and evidence -146573 − 7571 USD Exact free cash flow: -154144 USD 2019-04-01 – 2020-03-31: -146573 USD · Inspect Operating Cash Flow · Source 2019-04-01 – 2020-03-31: 7571 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zhong Yuan Bio-Technology Holdings Ltd · 2020-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Free cash flow: -154144 USD Concept: free-cash-flow Period: 2019-04-01 to 2020-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -146573 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997322001360/zhongyuan_f1.htm#2031728 Filing: 000107997322001360 Input fundies:CapitalExpenditure: 7571 USD (2019-04-01 to 2020-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997322001360/zhongyuan_f1.htm#2036361 Filing: 000107997322001360 The citation records this snapshot. The page link may show a newer release later.
2021 2020-04-01 – 2021-03-31	−USD 28,022 Exact value Exact value: -28022 USD 2020-04-01 – 2021-03-31: -28022 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zhong Yuan Bio-Technology Holdings Ltd · 2021-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Net Income: -28022 USD Concept: fundies:NetIncome Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ANetIncome&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:NetIncome: -28022 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2745164 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	USD 309,195 Exact value Exact value: 309195 USD 2020-04-01 – 2021-03-31: 309195 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zhong Yuan Bio-Technology Holdings Ltd · 2021-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Operating Cash Flow: 309195 USD Concept: fundies:OperatingCashFlow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3AOperatingCashFlow&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 309195 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2587987 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	USD 5,632 Exact value Exact value: 5632 USD 2020-04-01 – 2021-03-31: 5632 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zhong Yuan Bio-Technology Holdings Ltd · 2021-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Capital Expenditure: 5632 USD Concept: fundies:CapitalExpenditure Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ACapitalExpenditure&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5632 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2590471 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	USD 303,563 Calculation and evidence 309195 − 5632 USD Exact free cash flow: 303563 USD 2020-04-01 – 2021-03-31: 309195 USD · Inspect Operating Cash Flow · Source 2020-04-01 – 2021-03-31: 5632 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zhong Yuan Bio-Technology Holdings Ltd · 2021-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Free cash flow: 303563 USD Concept: free-cash-flow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 309195 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2587987 Filing: 000107997324001482 Input fundies:CapitalExpenditure: 5632 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2590471 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.
2022 2021-04-01 – 2022-03-31	−USD 1.13 million Exact value Exact value: -1125565 USD 2021-04-01 – 2022-03-31: -1125565 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zhong Yuan Bio-Technology Holdings Ltd · 2022-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Net Income: -1125565 USD Concept: fundies:NetIncome Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ANetIncome&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1125565 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2744389 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	−USD 255,747 Exact value Exact value: -255747 USD 2021-04-01 – 2022-03-31: -255747 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zhong Yuan Bio-Technology Holdings Ltd · 2022-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Operating Cash Flow: -255747 USD Concept: fundies:OperatingCashFlow Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3AOperatingCashFlow&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -255747 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2587445 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: -0 USD 2021-04-01 – 2022-03-31: -0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zhong Yuan Bio-Technology Holdings Ltd · 2022-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Capital Expenditure: -0 USD Concept: fundies:CapitalExpenditure Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ACapitalExpenditure&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: -0 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2590022 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	−USD 255,747 Calculation and evidence -255747 − -0 USD Exact free cash flow: -255747 USD 2021-04-01 – 2022-03-31: -255747 USD · Inspect Operating Cash Flow · Source 2021-04-01 – 2022-03-31: -0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zhong Yuan Bio-Technology Holdings Ltd · 2022-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Free cash flow: -255747 USD Concept: free-cash-flow Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -255747 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2587445 Filing: 000107997324001482 Input fundies:CapitalExpenditure: -0 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2590022 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.
2023 2022-04-01 – 2023-03-31	−USD 2.2 million Exact value Exact value: -2204126 USD 2022-04-01 – 2023-03-31: -2204126 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zhong Yuan Bio-Technology Holdings Ltd · 2023-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Net Income: -2204126 USD Concept: fundies:NetIncome Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ANetIncome&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2204126 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2323287 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	−USD 1.03 million Exact value Exact value: -1025359 USD 2022-04-01 – 2023-03-31: -1025359 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zhong Yuan Bio-Technology Holdings Ltd · 2023-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Operating Cash Flow: -1025359 USD Concept: fundies:OperatingCashFlow Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3AOperatingCashFlow&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1025359 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1604699 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	USD 22,369 Exact value Exact value: 22369 USD 2022-04-01 – 2023-03-31: 22369 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Zhong Yuan Bio-Technology Holdings Ltd · 2023-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Capital Expenditure: 22369 USD Concept: fundies:CapitalExpenditure Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ACapitalExpenditure&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22369 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2378328 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	−USD 1.05 million Calculation and evidence -1025359 − 22369 USD Exact free cash flow: -1047728 USD 2022-04-01 – 2023-03-31: -1025359 USD · Inspect Operating Cash Flow · Source 2022-04-01 – 2023-03-31: 22369 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Zhong Yuan Bio-Technology Holdings Ltd · 2023-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Free cash flow: -1047728 USD Concept: free-cash-flow Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1025359 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1604699 Filing: 000107997324001482 Input fundies:CapitalExpenditure: 22369 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#2378328 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.
2024 2023-04-01 – 2024-03-31	USD 271,869 Exact value Exact value: 271869 USD 2023-04-01 – 2024-03-31: 271869 USD Inspect Net Income Open source Share or cite Citation for Net Income · Zhong Yuan Bio-Technology Holdings Ltd · 2024-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Net Income: 271869 USD Concept: fundies:NetIncome Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3ANetIncome&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:NetIncome: 271869 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1767439 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	−USD 745,816 Exact value Exact value: -745816 USD 2023-04-01 – 2024-03-31: -745816 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Zhong Yuan Bio-Technology Holdings Ltd · 2024-03-31 Zhong Yuan Bio-Technology Holdings Ltd (edgar:1672886) Operating Cash Flow: -745816 USD Concept: fundies:OperatingCashFlow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T13:59:48Z Snapshot: 9434c62ffdf9b840158e9859af6b7500e9a4313552a3abdefeb4a5b998130ea7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1672886/explain?concept=fundies%3AOperatingCashFlow&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -745816 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1672886/000107997324001482/zhybf_20f.htm#1604238 Filing: 000107997324001482 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

36 filings · 419 latest values · 419 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001672886, 1672886, edgar:1672886

Also known as Agate Island Acquisition Corp, CHINA BIOTECH Co CORP, CHINA BIOTECH HOLDINGS Ltd (del), ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED, Zhong Yuan Bio-Technology Holdings Ltd

Zhong Yuan Bio-Technology Holdings Ltd

Latest quarter

Revenue

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2024 2023-04-01 – 2024-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation